Overview

Chemoablation for Low-Grade Bladder Cancer

Status:
RECRUITING

Trial end date:
2027-11-01

Target enrollment:

Participant gender:

Summary

The goal of this single arm, prospective, open-label, investigator-initiated Phase 2 clinical trial is to evaluate the efficacy of intravesical chemoablation in patients with low grade bladder cancer.

Phase:

PHASE2

Details

Lead Sponsor:

Ekaterina Laukhtina

Treatments:

Gemcitabine